David Einhorn - DME Capital Management,
Period: Q1 2026
Portfolio date: 31 Mar 2026
No. of stocks: 45
Portfolio value: $3,190,735,190
Holding/activity history for Neubase Therapeutics Inc (NBSE)
| Period |
Shares |
% of Portfolio |
Activity |
% Change to Portfolio |
Reported Price |
Value |
Filing |
| 2024 Q2 |
0 |
0.00 |
Sell 100.00%
|
<0.01 |
|
|
SEC |
| 2024 Q1 |
136,350 |
<0.01 |
|
|
$0.45 |
$61,344 |
SEC |